These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 15931384)

  • 41. Efficacy of Adoptive T-cell Therapy Is Improved by Treatment with the Antioxidant N-Acetyl Cysteine, Which Limits Activation-Induced T-cell Death.
    Scheffel MJ; Scurti G; Simms P; Garrett-Mayer E; Mehrotra S; Nishimura MI; Voelkel-Johnson C
    Cancer Res; 2016 Oct; 76(20):6006-6016. PubMed ID: 27742673
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CD8+ T cell concentration determines their efficiency in killing cognate antigen-expressing syngeneic mammalian cells in vitro and in mouse tissues.
    Budhu S; Loike JD; Pandolfi A; Han S; Catalano G; Constantinescu A; Clynes R; Silverstein SC
    J Exp Med; 2010 Jan; 207(1):223-35. PubMed ID: 20065066
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cancer therapy in mice using a pure population of CD8
    Stringhini M; Spadafora I; Catalano M; Mock J; Probst P; Spörri R; Neri D
    Cancer Immunol Immunother; 2021 Nov; 70(11):3183-3197. PubMed ID: 33796916
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adoptive CD8
    Fu J; Yu A; Tang J; He B; Chen W
    Am J Transl Res; 2020; 12(11):7262-7274. PubMed ID: 33312365
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Selection bias: maintaining less-differentiated T cells for adoptive immunotherapy.
    Xu Y; Dotti G
    J Clin Invest; 2016 Jan; 126(1):35-7. PubMed ID: 26657855
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Amazing IL-9: revealing a new function for an "old" cytokine.
    Schmitt E; Bopp T
    J Clin Invest; 2012 Nov; 122(11):3857-9. PubMed ID: 23064368
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Accumulation of neutrophils in the spleen of mice immunized with cells of allogenic tumors.
    Pobezinskii LA; Pobezinskaya EL; Zvezdova ES; Petrishchev VN; Grinenko TS; Baturina IA; Anfalova TV; Khromykh LM; Vasil'eva TV; Kazanskii DB
    Dokl Biol Sci; 2005; 402():224-9. PubMed ID: 16121951
    [No Abstract]   [Full Text] [Related]  

  • 48. HIF1α or HIF2α: Enhancing CD8
    Chen J
    Cancer Immunol Res; 2021 Apr; 9(4):364. PubMed ID: 34003767
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CD8
    Fernández-García J; Franco F; Parik S; Altea-Manzano P; Pane AA; Broekaert D; van Elsen J; Di Conza G; Vermeire I; Schalley T; Planque M; van Brussel T; Schepers R; Modave E; Karakach TK; Carmeliet P; Lambrechts D; Ho PC; Fendt SM
    Cell Rep; 2022 Nov; 41(7):111639. PubMed ID: 36384124
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cancer immunotherapy: Killers on sterols.
    Dustin ML
    Nature; 2016 Mar; 531(7596):583-4. PubMed ID: 26982727
    [No Abstract]   [Full Text] [Related]  

  • 51. Impact of T cell selection methods in the success of clinical adoptive immunotherapy.
    Ramírez N; Beloki L; Ciaúrriz M; Rodríguez-Calvillo M; Escors D; Mansilla C; Bandrés E; Olavarría E
    Cell Mol Life Sci; 2014 Apr; 71(7):1211-24. PubMed ID: 24077876
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ex vivo generation of highly purified and activated natural killer cells from human peripheral blood.
    Saito S; Harada Y; Morodomi Y; Onimaru M; Yoshida K; Kyuragi R; Matsubara H; Yonemitsu Y
    Hum Gene Ther Methods; 2013 Aug; 24(4):241-52. PubMed ID: 23885718
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Persistent antigen at vaccination sites induces tumor-specific CD8⁺ T cell sequestration, dysfunction and deletion.
    Hailemichael Y; Dai Z; Jaffarzad N; Ye Y; Medina MA; Huang XF; Dorta-Estremera SM; Greeley NR; Nitti G; Peng W; Liu C; Lou Y; Wang Z; Ma W; Rabinovich B; Sowell RT; Schluns KS; Davis RE; Hwu P; Overwijk WW
    Nat Med; 2013 Apr; 19(4):465-72. PubMed ID: 23455713
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ex vivo interleukin-12-priming during CD8(+) T cell activation dramatically improves adoptive T cell transfer antitumor efficacy in a lymphodepleted host.
    Rubinstein MP; Cloud CA; Garrett TE; Moore CJ; Schwartz KM; Johnson CB; Craig DH; Salem ML; Paulos CM; Cole DJ
    J Am Coll Surg; 2012 Apr; 214(4):700-7; discussion 707-8. PubMed ID: 22360982
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Toll-like receptor agonists: are they good adjuvants?
    Gnjatic S; Sawhney NB; Bhardwaj N
    Cancer J; 2010; 16(4):382-91. PubMed ID: 20693851
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characterization of the recognition and functional heterogeneity exhibited by cytokine-induced killer cell subsets against acute myeloid leukaemia target cell.
    Linn YC; Lau SK; Liu BH; Ng LH; Yong HX; Hui KM
    Immunology; 2009 Mar; 126(3):423-35. PubMed ID: 18778291
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Phenotype and functional characterization of long-term gp100-specific memory CD8+ T cells in disease-free melanoma patients before and after boosting immunization.
    Walker EB; Haley D; Petrausch U; Floyd K; Miller W; Sanjuan N; Alvord G; Fox BA; Urba WJ
    Clin Cancer Res; 2008 Aug; 14(16):5270-83. PubMed ID: 18698047
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adoptive immunotherapy for cancer: building on success.
    Gattinoni L; Powell DJ; Rosenberg SA; Restifo NP
    Nat Rev Immunol; 2006 May; 6(5):383-93. PubMed ID: 16622476
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Toward improved immunocompetence of adoptively transferred CD8+ T cells.
    Speiser DE; Romero P
    J Clin Invest; 2005 Jun; 115(6):1467-9. PubMed ID: 15931384
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Adoptive transfer of an anti-MART-1(27-35)-specific CD8+ T cell clone leads to immunoselection of human melanoma antigen-loss variants in SCID mice.
    Lozupone F; Rivoltini L; Luciani F; Venditti M; Lugini L; Cova A; Squarcina P; Parmiani G; Belardelli F; Fais S
    Eur J Immunol; 2003 Feb; 33(2):556-66. PubMed ID: 12645955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.